Important Notice: Website Migration in Progress
We’ve recently completed a major system migration to enhance your experience. As a result, some services may not be working as expected.
If you are experiencing any e-mail related issues then please contact us using the details below.
| Department | Contact Information |
|---|---|
| Stock Enquiries | customerservices_uk@daiichisankyo.com |
| Medical Information | medinfo@daiichi-sankyo.co.uk |
| Adverse Event Reporting | pharmacovigilance_uk@daiichisankyo.com
|
| Supplier Invoice Payments | DSUK-AP_uk@daiichisankyo.com |
| Press Office | pressoffice_uk@daiichisankyo.com |
Daiichi Sankyo UK Ltd is a UK affiliate company with corporate origins in Japan. We create and supply innovative products to help the NHS deliver patient care in the fields of cardiovascular disease and oncology.
Our company was founded in 2006 through the merger of the well-established Japanese companies Daiichi and Sankyo in Europe. Daiichi Sankyo is a global pharmaceutical company based in Japan that has a presence in more than 20 countries around the world. With a rich legacy of over 100 years of scientific expertise, we are the pioneer behind leading pharmaceuticals that have contributed to the improvement of countless lives. Our global headquarters is in Tokyo. In Europe, we have affiliates in 14 countries and Canada with about 2,500 employees. Our European headquarters is in Munich, Germany, and not far from there, one of our global production plants is located in Pfaffenhofen.
UK/DSC/06/25/0003 - June 2025
